Stress Echo Safe for ER Triage of Patients With Chest Pain

Share this content:

(HealthDay News) -- For patients presenting to the emergency department with chest pain, a smaller proportion are hospitalized after undergoing stress echocardiography (SE) versus coronary computed tomography angiography (CCTA), according to a study published online June 13 in JACC: Cardiovascular Imaging.

Jeffrey M. Levsky, M.D., Ph.D., from Albert Einstein College of Medicine in Bronx, N.Y., and colleagues randomized low-to-intermediate-risk emergency department acute chest pain patients without known coronary artery disease and a negative initial serum troponin level to immediate CCTA (201 patients) or SE (199 patients).

The researchers found that 19 and 11 percent of CCTA and SE patients, respectively, were hospitalized at presentation (P = 0.026). For discharged patients, the median emergency department length of stay was 5.4 and 4.7 hours for CCTA and SE, respectively (P < 0.001). The median hospital length of stay was 58 and 34 hours for CCTA and SE, respectively (P = 0.002). Over a median follow-up of 24 months there were 11 and seven major adverse cardiovascular events for CCTA and SE, respectively (P = 0.47). The median/mean complete initial work-up radiation exposure was 6.5/7.7 and 0/0.96 milliSieverts, respectively, for CCTA and SE (P < 0.001).

"SE hospitalized a smaller proportion of patients with a shorter length of stay than CCTA and was safe. SE should be considered an appropriate option for emergency department chest pain triage," the authors write.

One author disclosed financial ties to Kryon.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »